Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Translational Internal Medicine

4 Issues per year

Open Access
See all formats and pricing
More options …

Biomarkers in acute kidney injury, sepsis and ARDS: Guiding clinicians…. but where to?

Patrick M. Honore / Rita Jacobs / Elisabeth De Waele / Viola Van Gorp
  • Department of ICU, Universitair Ziekenhuis Brussel, VUB University, Brussels, Ziekenhuis oost-Limburgh, Genk, Belgium
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Olivier Joannes-Boyau / Jouke De Regt / Willem Boer / Herbert D Spapen
Published Online: 2015-04-24 | DOI: https://doi.org/10.4103/2224-4018.147734


  • 1. Honore PM, Jacobs R, Joannes-Boyau O, Verfaillie L, De Regt J, Van Gorp V, et al. Biomarkers for early diagnosis of AKI in the ICU: Ready for prime time use at the bedside? Ann Intensive Care 2012;2:24.Google Scholar

  • 2. Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: A multicenter pooled analysis of prospective studies. J Am Coll Cardiol 2011;57:1752-61.Web of ScienceCrossrefGoogle Scholar

  • 3. Haase M, Kellum JA, Ronco C. Subclinical AKI--an emerging syndrome with important consequences. Nat Rev Nephrol 2012;8:735-9.Web of ScienceCrossrefGoogle Scholar

  • 4. Ronco C, Kellum JA, Haase M. Subclinical AKI is still AKI. Crit Care 2012;16:313.Web of ScienceGoogle Scholar

  • 5. Ronco C, Stacul F, McCullough PA. Subclinical acute kidney injury (AKI) due to iodine-based contrast media. Eur Radiol 2013;23:319-23.CrossrefWeb of ScienceGoogle Scholar

  • 6. Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013;17:R25.Web of ScienceCrossrefGoogle Scholar

  • 7. Hoste EA, McCullough PA, Kashani K, Chawla LS, Joannidis M, Shaw AD, et al. Sapphire Investigators. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant 2014;29:2054-61.Google Scholar

  • 8. Prucha M, Bellingan G, Zazula R. Sepsis biomarkers. Clin Chim Acta 2014;440:97-103.Web of ScienceCrossrefGoogle Scholar

  • 9. Yoo H, Ku SK, Kim SW, Bae JS. Early Diagnosis of Sepsis Using Serum Hemoglobin Subunit Beta. Inflammation 2014 Oct 23. [Epub ahead of print].Google Scholar

  • 10. Hjortrup PB, Haase N, Treschow F, Møller MH, Perner A. Predictive value of NGAL for use of renal replacement therapy in patients with severe sepsis. Acta Anaesthesiol Scand 2015;59:25-34.Web of ScienceCrossrefGoogle Scholar

  • 11. Ronco C, Legrand M, Goldstein SL, Hur M, Tran N, Howell EC, et al.Neutrophil gelatinase-associated lipocalin: Ready for routine clinical use? An international perspective. Blood Purif 2014;37:271-85. Web of ScienceCrossrefGoogle Scholar

About the article

Published Online: 2015-04-24

Published in Print: 2014-12-01

Citation Information: Journal of Translational Internal Medicine, Volume 2, Issue 4, Pages 147–149, ISSN (Online) 2224-4018, DOI: https://doi.org/10.4103/2224-4018.147734.

Export Citation

© 2015. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Comments (0)

Please log in or register to comment.
Log in